Oncopeptides AB (publ) (LON:0RN4)
London
· Delayed Price · Currency is GBP · Price in SEK 1.700
-0.102 (-5.66%)
At close: May 30, 2025
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 13.27M SEK in the quarter ending March 31, 2025, with 161.57% growth. This brings the company's revenue in the last twelve months to 39.84M, up 1.72% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.
Revenue (ttm)
39.84M SEK
Revenue Growth
+1.72%
P/S Ratio
9.43
Revenue / Employee
498.04K SEK
Employees
80
Market Cap
28.96M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |